Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Y. Santaana
Pcv19 - Patterns of Anticoagulation Control and Clinical Outcomes in Atrial Fibrillation Patients Treated With Vitamin K Antagonists: A Real-World Study Using Population-Based Data and Group-Based Trajectory Models
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv115 - Quality of Inr Control and Switching to Doac Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study.
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Quality of INR Control and Switching to Non-Vitamin K Oral Anticoagulants Between Women and Men With Atrial Fibrillation Treated With Vitamin K Antagonists in Spain. A Population-Based, Real-World Study
PLoS ONE
Multidisciplinary
Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
Patient Characteristics and Bleeding Events in Nonvalvular Atrial Fibrillation Patients Treated With Apixaban or Vitamin K Antagonists: Real-World Evidence From Italian Administrative Databases
Journal of Comparative Effectiveness Research
Health Policy
Outcomes in a Warfarin-Treated Population With Atrial Fibrillation
JAMA Cardiology
Cardiovascular Medicine
Cardiology
Clinical Outcomes and Cost-Effectiveness of Novel Oral Anticoagulants Incorporating Real-World Elderly Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Exposure to Vitamin K Antagonists and Kidney Function Decline in Patients With Atrial Fibrillation and Chronic Kidney Disease
Research and Practice in Thrombosis and Haemostasis
Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental